Advertisement
Screener

Lucira Health, Inc. Increase (Decrease) in Accounts Payable

Lucira Health, Inc. Increase (Decrease) in Accounts Payable

Lucira Health, Inc. reported Increase (Decrease) in Accounts Payable of $4.05 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2022-11-14

  • Lucira Health, Inc. increase (decrease) in accounts payable for the quarter ending 2022-09-30 was $3.69M, a 2.77% decline year-over-year.
  • Lucira Health, Inc. increase (decrease) in accounts payable for the quarter ending 2022-06-30 was -$3.13M.
  • Lucira Health, Inc. increase (decrease) in accounts payable for the quarter ending 2022-03-31 was $3.50M, a 32.36% decline year-over-year.
  • Lucira Health, Inc. increase (decrease) in accounts payable for the quarter ending 2021-12-31 was $8.45M.
  • Lucira Health, Inc. increase (decrease) in accounts payable for fiscal 2021 was $14.92M, a 366.86% increase from fiscal 2020.
  • Lucira Health, Inc. increase (decrease) in accounts payable for fiscal 2020 was $3.20M.
Period endIncrease (Decrease) in Accounts Payable 3 monthIncrease (Decrease) in Accounts Payable 6 monthIncrease (Decrease) in Accounts Payable 9 monthIncrease (Decrease) in Accounts Payable 12 month
2022-09-30$3.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$554.00K
derived: sum of 2 quarters · filed 2022-11-14
$4.05M
10-Q · filed 2022-11-14
$12.50M
derived: sum of 4 quarters · filed 2022-11-14
2022-06-30-$3.13M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
$362.00K
10-Q · filed 2022-08-15
$8.81M
derived: sum of 3 quarters · filed 2022-08-15
$12.61M
derived: sum of 4 quarters · filed 2022-11-14
2022-03-31$3.50M
10-Q · filed 2022-05-16
$11.95M
derived: sum of 2 quarters · filed 2022-05-16
$15.74M
derived: sum of 3 quarters · filed 2022-11-14
$13.25M
derived: sum of 4 quarters · filed 2022-11-14
2021-12-31$8.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
$12.24M
derived: sum of 2 quarters · filed 2022-11-14
$9.75M
derived: sum of 3 quarters · filed 2022-11-14
$14.92M
10-K · filed 2022-03-31
2021-09-30$3.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$1.30M
derived: sum of 2 quarters · filed 2022-11-14
$6.47M
10-Q · filed 2022-11-14
$6.00M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$2.49M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
$2.68M
10-Q · filed 2022-08-15
$2.21M
derived: sum of 3 quarters · filed 2022-08-15
$5.35M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31$5.17M
10-Q · filed 2022-05-16
$4.70M
derived: sum of 2 quarters · filed 2022-05-16
$7.84M
derived: sum of 3 quarters · filed 2022-05-16
$8.46M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31-$471.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
$2.67M
derived: sum of 2 quarters · filed 2022-03-31
$3.29M
derived: sum of 3 quarters · filed 2022-03-31
$3.20M
10-K · filed 2022-03-31
2020-09-30$3.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$3.76M
derived: sum of 2 quarters · filed 2021-11-12
$3.67M
10-Q · filed 2021-11-12
2020-06-30$619.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13
$527.00K
10-Q · filed 2021-08-13
2020-03-31-$92.00K
10-Q · filed 2021-05-17